Meanwhile, for the CDKN2B-AS antisense lncRNA, we reviewed all three promoters and found the highest expression in carcinosarcoma cells, gastrointestinal carcinoma cells, osteosarcoma cells, lens epithelial cells and gall bladder carcinoma cells. Here, CDKN2B is linked to digestive system carcinoma.